EazyPharmacy - Delivering Authentic Medicines from Your Local Trusted Pharmacies in Just 30 Minutes!
.png)
Our Vision
At Eazy Pharmacy, we are on a mission to bridge the gap in timely medicine delivery and improve access to trusted healthcare providers. While healthcare in India is advancing rapidly, there’s a critical need for fast, reliable, and affordable delivery solutions. Our goal is simple:
- chevron_right 30-Minute Medicine Delivery in metro cities.
- chevron_right Same-Day Delivery in rural areas.
We aim to make healthcare more accessible and efficient, ensuring patients receive their medications quickly.
Why Now? The Market Opportunity
The Indian pharmaceutical market, valued at approximately ₹2.28 trillion (₹2,28,000 crores), is predominantly controlled by unorganized players, with 85%-90% of the market comprising small, independent pharmacies.
How Eazy Pharmacy Stands Out
- Zero-Inventory Model: Reduces operational costs and improves scalability.
- Hyperlocal Delivery: 30-minute delivery in metro cities, same-day delivery in rural areas.
- Empowering Local Pharmacies: Connects them with wider customer bases while maintaining their operational autonomy.
- Customer-Centric Innovation: Features such as real-time tracking, on-demand consultations, and easy access to medications.
Growth Projections and Valuation
The estimated valuation for the startup is ₹8–12 crores initially, with significant growth potential. By Year 5, it aims for national expansion, targeting ₹800–1,000 crores in valuation with diverse revenue streams.
Reference Healthtech Startups: Inspiring Growth Potential
To validate our valuation estimates, we analyzed comparable Indian healthtech platforms. Notable examples include Tata 1mg, which grew from a ₹150 crore pre-launch valuation to ₹21,000 crores, and PharmEasy, which increased from ₹250 crores to ₹24,000 crores, among others like Practo and Netmeds showing significant growth.
Why Invest in Eazy Pharmacy?
First-Mover Advantage:
- Serving unorganized pharmacies with a scalable, hyperlocal model.
- Bridging gaps that existing players haven’t addressed, especially in rural areas.
Revenue Streams:
- Delivery fees.
- Pharmacy partnerships.
- Customer subscriptions and healthcare value-added services.
Strategic Exit Opportunities:
- Acquisition by larger players (e.g., Tata 1mg, PharmEasy) or IPO.
- High-growth potential with realistic milestones.
Investor Security:
- Convertible Notes for smaller investments (₹5,000–₹10,000), converting to equity in future funding rounds.
- Equity Shares for larger investments, offering direct ownership and returns based on growth.
Join Our Journey to Transform Healthcare
By investing in Eazy Pharmacy, you’re not just funding a startup—you’re supporting a vision to revolutionize India’s healthcare delivery system. Together, we can create a future where timely, affordable, and reliable healthcare is accessible to all.
"Trusted Market Insights & Benchmarks"
"Explore reliable sources and industry benchmarks that validate the market potential, app valuations, and EazyPharmacy’s competitive edge. These insights build transparency and trust in our vision."
| Source | Link | Details |
|---|---|---|
| Grandviewresearch - India Pharmacy Market Size & Outlook, 2025-2030 | https://www.grandviewresearch.com/horizon/outlook/pharmacy-market/india | The pharmacy market in India is expected to reach a projected revenue of US$ 48,383.7 million by 2030. |
| India Pharmaceutical Industry Research (Yahoo Finance) | https://finance.yahoo.com/news/india-pharmaceutical-industry-research-2024-155000339.html | India’s pharma market to grow to ₹8,90,000 crores by 2030 at 8.75% CAGR. |
| Statista: Online Pharmacy Market | https://www.statista.com/outlook/hmo/digital-health/online-pharmacy/india | Online pharmacy projected to grow to ₹14,000 crores by 2029 at a 13.33% CAGR. |
| Invest India: E-Pharmacies Bridging Gap in Healthcare | https://www.investindia.gov.in/team-india-blogs/e-pharmacies-bridging-gap-indian-healthcare | E-pharmacies are expected to grow to ₹36,000 crores by 2025 with 44% CAGR. |
| PharmEasy Valuation | https://www.crunchbase.com/organization/pharmeasy | Valued at $5.6 billion (₹45,000 crores) after recent funding rounds. |
| 1mg Valuation | https://www.crunchbase.com/organization/1mg | Acquired by Tata Digital, valued at approximately $450 million (₹3,750 crores). |
| NetMeds Valuation | https://www.crunchbase.com/organization/netmeds | Acquired by Reliance Retail for approximately ₹620 crores. |
VMK Heights, Flat No. 102, 1st Floor, Sai Nagar, Madhapur, Hyderabad - 500081, Telangana, India
Phone: +91 8050069339
Email: support@eazypharmacy.in